Cargando…

(90)Y Radioembolization: Telemedicine During COVID-19 Outbreak, Opportunity for Prime Time

Detalles Bibliográficos
Autores principales:	Quek, Lawrence, Kannivelu, Anbalagan, Pua, Uei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Nuclear Medicine 2020
Materias:	Covid Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262230/ https://www.ncbi.nlm.nih.gov/pubmed/32303600 http://dx.doi.org/10.2967/jnumed.120.246389

Ejemplares similares

Transarterial radioembolization with Yttrium-90: current status and future prospects
por: Yang, Hua-Yu, et al.
Publicado: (2020)

Managing Endovascular Workload during COVID-19 Outbreak—The Singapore Experience
por: Quek, Lawrence Han Hwee, et al.
Publicado: (2020)

Modified Retroperitoneal Access for Percutaneous Intervention after Pancreaticoduodenectomy
por: Pua, Uei, et al.
Publicado: (2013)

Radioembolization and the Dynamic Role of (90)Y PET/CT
por: Pasciak, Alexander S., et al.
Publicado: (2014)

Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2020)

Side Effects of Yttrium-90 Radioembolization
por: Riaz, Ahsun, et al.
Publicado: (2014)

Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres
por: Bouvry, C., et al.
Publicado: (2018)

Life in 90 words: opportunities for person-centred care amidst COVID-19
por: Theodoros, Theo, et al.
Publicado: (2020)

Boosting telemedicine through remote monitoring of cardiac electronic devices during the Italian COVID-19 outbreak
por: Mugnai, Giacomo, et al.
Publicado: (2021)

Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases
por: Tsang, Erica S., et al.
Publicado: (2020)

Temporary Reversal of Hepatoenteric Collaterals during (90)Y Radioembolization Planning and Administration
por: Habibollahi, Peiman, et al.
Publicado: (2022)

Early experience in the COVID-19 pandemic from a vascular surgery unit in a Singapore tertiary hospital
por: Leong Tan, Glenn Wei, et al.
Publicado: (2020)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
por: Raval, Mihir, et al.
Publicado: (2014)

Simplification of dosimetry in (90)Y-radioembolization therapy by dual planar images
por: Abuqbeitah, Mohammad, et al.
Publicado: (2022)

Single-Compartment Dose Prescriptions for Ablative (90)Y-Radioembolization Segmentectomy
por: Kappadath, Srinivas Cheenu, et al.
Publicado: (2023)

Long-term outcome analysis of Y90 radioembolization in hepatocellular carcinoma
por: Lee, Hannah M., et al.
Publicado: (2023)

Smartphones and telemedicine for older people in China: Opportunities and challenges
por: Zhang, Chi
Publicado: (2022)

Commentary: Almost ready for prime time
por: Wei, Lawrence M.
Publicado: (2020)

Telemedicine and intraductal papillary mucinous neoplasms: Analysis of a new follow-up strategy during COVID-19 outbreak
por: Farguell, J., et al.
Publicado: (2022)

Embolization of a Bronchial Artery–Pulmonary Artery Arterio–Venous Malformation
por: Pua, Uei, et al.
Publicado: (2019)

Who Was the First Doctor to Report the COVID-19 Outbreak in Wuhan, China?
por: Li, Xixing, et al.
Publicado: (2020)

Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with (90)Y microspheres
por: Yim, Sun Young, et al.
Publicado: (2014)

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
por: Lee, Victor Ho-Fun, et al.
Publicado: (2015)

Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
por: Kallini, Joseph Ralph, et al.
Publicado: (2016)

Internal dosimetry for radioembolization therapy with Yttrium‐90 microspheres
por: Fallahpoor, Maryam, et al.
Publicado: (2017)

History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
por: Saini, Aman, et al.
Publicado: (2019)

Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis
por: Kim, Hyo-Cheol
Publicado: (2022)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
por: Yu, Chun-Yen, et al.
Publicado: (2023)

Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization
por: D’Arienzo, Marco, et al.
Publicado: (2017)

Genomic mutations and histopathologic biomarkers in Y(90) radioembolization for chemorefractory colorectal liver metastases
por: Dendy, Meaghan S., et al.
Publicado: (2018)

Deprescribing: A Prime Opportunity to Optimize Care of Cancer Patients
por: Chaput, Genevieve, et al.
Publicado: (2023)

Telemedicine in Rheumatology at the Advent of the COVID-19 Pandemic
por: Gkrouzman, Elena, et al.
Publicado: (2020)

Yttrium-90 Radioembolization: An Unusual Cause of Radiating Abdominal Pain
por: Estes, Derek J., et al.
Publicado: (2019)

Imaging Evaluation Following (90)Y Radioembolization of Liver Tumors: What Radiologists Should Know
por: Joo, Ijin, et al.
Publicado: (2018)

The role of (90)Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review
por: Braat, M. N. G. J. A., et al.
Publicado: (2016)

Feasibility of imaging (90)Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning
por: Kunnen, Britt, et al.
Publicado: (2020)

Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization
por: Lopez, Benjamin P., et al.
Publicado: (2022)

Telemedicine in pediatric otolaryngology: Ready for prime time?
por: Schafer, Austin, et al.
Publicado: (2020)

Application of Telemedicine in Diabetes Care: The Time is Now
por: Aberer, Felix, et al.
Publicado: (2021)

The Role of Nuclear Medicine for COVID-19: Time to Act Now
por: Juengling, Freimut D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ls08988bclem24844oo35ld2ng